Biogen's Alzheimer's drug gets negative European panel vote

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. AXP
7. TMUS
8. SPY
9. CVS
10. UNH

Go back to Biogen's Alzheimer's drug gets negative European panel vote

The US, Not EU Market is Bulk of Biogen (BIIB) Aduhelm's Value, lecanemab Offers Further Potential Upside - Analyst

November 17, 2021 9:15 AM EST

Earlier today, Biogen Inc. (Nasdaq: BIIB) and Eisai Co., Ltd announces an update on the ongoing review of the Marketing Authorization Application for aducanumab 100 mg/mL concentrate solution for infusion for the treatment of Alzheimers disease by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

Following an oral explanation held at the November meeting... More